Hjem › Kronisk nyresykdom › Ohio
Kliniske studier for Kronisk nyresykdom i Ohio
15 studier for Kronisk nyresykdom søker deltakere på steder i Ohio.
Byer i Ohio
Offisiell studietekst (engelsk)
A Study of Praliciguat in Participants With Focal Segmental Glomerulosclerosis (FSGS)
- Investigator Site #20, Cleveland
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 1. okt. 2026 · NCT07268638A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event
- Velocity Clinical Research, Cincinnati, Springdale, Cincinnati
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 30. sep. 2026 · NCT07783802A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure
- Research Site, Canton
- Research Site, Cincinnati
- Research Site, Cincinnati
- og 3 flere
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 25. sep. 2026 · NCT06742723A Phase III Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With CKD Stage 3b and 4 (BalanceD-CKD)
- Research Site, Cincinnati
- Research Site, Cincinnati
RekruttererFase 3
Alder 18 til 99 · Alle kjønn · Oppdatert 24. sep. 2026 · NCT07624305Study to Assess the Efficacy, Pharmacokinetics, Safety and Tolerability of Atrasentan in Pediatric Patients With Primary IgAN
- Cincinnati Childrens Hospital MC, Cincinnati
RekruttererFase 3
Alder 2 til 18 · Alle kjønn · Oppdatert 21. sep. 2026 · NCT07498335A Study to Find Out How EMPAgliflozin is Tolerated and if it Helps Children and Adolescents With Chronic KIDNEY Disease (EMPA-KIDNEY® Kids)
- Cincinnati Children's Hospital Medical Center, Cincinnati
- Cleveland Clinic, Cleveland
RekruttererFase 3
Alder 2 til 17 · Alle kjønn · Oppdatert 16. sep. 2026 · NCT07107945A Study to Investigate Outcomes With Elecoglipron Compared With Placebo in Adult Participants With Chronic Kidney Disease.
- Research Site, Cincinnati
- Research Site, Maumee
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 9. sep. 2026 · NCT07753993Monocytes in Subjects With Type 1 Diabetes and Chronic Kidney Disease
- Cleveland Clinic, Cleveland
RekruttererObservasjonsstudie
Alder 18 til 65 · Alle kjønn · Oppdatert 8. jul. 2026 · NCT06694558BZLF1 Peptide Vaccine (OSU-2131) With QS-21 for the Prevention of Epstein-Barr Virus Related Cancer in Patients Awaiting Solid Organ Transplants
- Ohio State University Comprehensive Cancer Center, Columbus
RekruttererFase 1Frivillige helsepersonell ønskes velkommen
Alder 18 til 65 · Alle kjønn · Oppdatert 2. jul. 2026 · NCT06741072Ferric Citrate and Chronic Kidney Disease in Children
- Cincinnati Children's Hospital Medical Center, Cincinnati
- Nationwide Children's, Columbus
RekruttererFase 2
Alder 6 til 18 · Alle kjønn · Oppdatert 17. apr. 2026 · NCT04741646A Study to Evaluate the Safety (Compared to Iron Sucrose), Efficacy and Pharmacokinetics of Ferumoxytol for the Treatment of Iron Deficiency Anemia (IDA) in Pediatric Subjects With Chronic Kidney Disease (CKD)
- Akron Nephrology Associates, Inc., Akron
RekruttererFase 3
Alder 2 til 17 · Alle kjønn · Oppdatert 17. apr. 2026 · NCT03619850Kidney Precision Medicine Project
- Cleveland Clinic, Cleveland
RekruttererObservasjonsstudie
Alder 18 og eldre · Alle kjønn · Oppdatert 14. apr. 2026 · NCT04334707A Trial of Etelcalcetide in Pediatric Participants With Secondary Hyperparathyroidism and Chronic Kidney Disease on Hemodialysis
- Cleveland Clinic Foundation, Cleveland
RekruttererFase 3
Alder 0 til 18 · Alle kjønn · Oppdatert 27. feb. 2026 · NCT03633708Transformative Research in Diabetic Nephropathy
- Ohio State University, Columbus
RekruttererObservasjonsstudie
Alder 18 til 100 · Alle kjønn · Oppdatert 27. feb. 2026 · NCT02986984A Study of a Novel Iron-based Phosphate Binder AP301 in Patients With Hyperphosphatemia in the U.S. and China
- US Renal Care - Alexis, Toledo
RekruttererFase 3
Alder 12 og eldre · Alle kjønn · Oppdatert 29. jan. 2026 · NCT06933472Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.